ISRO has shipped a key payload of Chandraya-2

Bengaluru, Apr 13: Fifteen new positive cases of coronavirus have been confirmed in Karnataka, taking the total number of affected in the state to 247, the Health department said on Monday.

"Fifteen new positive cases have been reported from last evening to this noon.... Till date 247 COVID-19 positive cases have been confirmed. This includes 6 deaths and 59 discharges," the department said in a mid-day situation report.

Among the 15 new cases thirteen are contacts of patients already tested positive, while one from Dodabballapura in Bengaluru Rural is with a travel history to Delhi, the other from Bengaluru city has Severe Acute Respiratory Infection (SARI).

Among the 13 contact cases tested positive four are from Hubballi in Dharwad district, three each from Malavalli in Mandya district and Raibag in Belagavi, two each from Bidar, and one from Mudhol in Bagalkote district.

Three out of 15 new cases are children- a 8 year-old girl from Malavalli in Mandya, 16-year old girl from Bidar and 14-year old boy from Raibag in Belagavi.

From across the state most number of infections have been reported in Bengaluru with 77, followed by Mysuru (48) and Belagavi (17).

Those discharged include 27 patients from Bengaluru, nine from Mysuru, seven from Dakshina Kannada, six from Chikkaballapura, three from Davangere, two each from Uttara Kannada and Kalaburagi, and one each from Udupi, Dharwad and Kodagu.

Among the dead, two are from Kalaburagi and one each from Bengaluru, Bagalkote, Gadag and Tumakuru.

Bengaluru, May 26: The Karnataka government today resolved to continue with the online method of education as a new normal in the field of higher education. 

Holding the review of the Higher Education department, Chief Minister B S Yediyurappa expressed interest in providing online education to students in higher educational institutes.

Yediyurappa directed the officials to look into the possibilities of extending online education from as early as Pre-University level so that the new method can easily be followed as they scale up the academic career. 

Keeping in mind the less expenditure and online teaching being cost-effective, Yediyurappa said, “If you compare online teaching with the regular classroom teaching, it is not only cost-effective but also helps in savings in terms of resources. Officials must look into the new method and start introducing it as early as PU classes.”

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.